Douglas DiRuggiero, DMSc, PA-C, Skin Cancer and Cosmetic Dermatology Center

Experts in dermatology share practice pearls to advanced practice providers and community dermatologists for the management of plaque psoriasis.

Jayme M. Heim, MSN, FNP-BC, discusses unmet needs in the treatment landscape of plaque psoriasis.

Douglas DiRuggiero, DMSc, PA-C, reviews how deucravacitinib impacts the quality of life for patients with plaque psoriasis.

Darren West, MPAS, PA-C, shares how often follow-up is required with deucravacitinib therapy in plaque psoriasis.

Andrea Nguyen, PA-C, MS, provides an overview of the safety considerations of deucravacitinib for the treatment of plaque psoriasis.

Experts in dermatology discuss what patients to consider treating with deucravacitinib, as well as comment on the comparative safety and efficacy of other therapies.

Experts in dermatology discuss the importance of deucravacitinib being an expansion of oral treatment modalities for plaque psoriasis, as well as the long-term data.

Jayme M. Heim, MSN, FNP-BC, reviews deucravacitinib as an oral treatment for moderate to severe plaque psoriasis, describing its unique mechanism of action.

Douglas DiRuggiero, DMSc, PA-C, discusses factors that contribute to switching a patient with plaque psoriasis from a topical to a systemic agent.

Darren West, MPAS, PA-C, reviews treatment failure as criteria for advanced practice providers to utilize a step-up treatment approach.

Andrea Nguyen, MS, PA-C, reviews commonly used therapies for the initial treatment of plaque psoriasis.

Jayme M. Heim, MSN, FNP-BC, discusses the various challenges care providers face when selecting treatment for patients with plaque psoriasis.

Douglas DiRuggiero, DMSc, PA-C, shares his approach to building trust in the patient-provider relationship when counseling patients about treatment of plaque psoriasis.

Darren West, MPAS, PA-C, and Douglas DiRuggiero, DMSc, PA-C, talk about how the treatment of plaque psoriasis has changed as understanding of the disease grows.

Experts in dermatology discuss how clinician understanding of plaque psoriasis has evolved over time.

Jayme M. Heim, MSN, FNP-BC, comments on the need for multidisciplinary care providers in light of comorbidities in plaque psoriasis.

Douglas DiRuggiero, DMSc, PA-C, reviews the role of nurse practitioners, physician assistants, and pharmacists in managing plaque psoriasis.

Clinical pearls regarding the management of patients with atopic dermatitis with newer treatment approaches as the field continues to evolve.

Strategies that can be used by healthcare professionals to help address patient concerns around atopic dermatitis.

Advice for healthcare professionals who treat atopic dermatitis to help them best manage patients and connect them to other supportive resources.

The importance of partnering with patients who have atopic dermatitis to best support them throughout their long-term journey with the condition.

Considerations regarding how to best select from and use newer therapies for atopic dermatitis.

Current barriers faced by healthcare professionals who treat atopic dermatitis and anticipation regarding opportunities emerging in the field.

Strategies used to evaluate patients and accurately diagnose atopic dermatitis in children and adults.

Experts in dermatology discuss patient education and clinical pearls to assist colleagues in the management of atopic dermatitis.

Margaret Bobonich, DNP, FNP-C, DCNP, FAANP, and Douglas DiRuggiero, DMSc, PA-C, provide insight into the emerging class of JAK inhibitors for atopic dermatitis including their pathophysiology, route of administration, and available clinical evidence.

Patient factors and disease characteristics that impact one’s treatment approach for atopic dermatitis.

Key players in dermatology clinics and steps taken to help patients receive access to newer therapies available to treat atopic dermatitis.

Reactions to the efficacy and safety of dupilumab treatment for atopic dermatitis as demonstrated by clinical trial data and real-world experience.

Experts in dermatology describe the topical treatment landscape of atopic dermatitis: corticosteroids, calcineurin inhibitors, crisaborole, and upcoming topical JAK inhibitors.